Skip to content

Examination of the effect of test food intake on menstrual-related symptoms

The effect of intake of food components that affect intestinal and oral factors on menstrual-related complaints in young women - A randomized, single-blind, placebo-controlled, parallel-group comparative study - - The effect of intake of food components that affect intestinal and oral factors on menstrual-related complaints in young women - A randomized, single-blind, placebo-controlled, parallel-group comparative study -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059159
Enrollment
50
Registered
2025-09-22
Start date
2025-09-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

The active food is taken for 10 weeks from the start date of the test food intake Subjects will be asked to take a placebo food for 10 weeks from the start date of taking the test food intake

Sponsors

Hokkaido University
Lead Sponsor
Morinaga Milk Industry Co., Ltd.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Those aged 18 to 24 Those enrolled at the university Person who has menstruation

Exclusion criteria

Exclusion criteria: People with food allergies. Those who cannot stop taking oligosaccharides or lactobacillus / bifidobacterium supplements during the study period. Pregnant women or those who intend to become pregnant during the study period. Those who are participating or planning to participate in other clinical trials during the period from 4 weeks before the pre-test until the end of the intake period. Those who are judged by the investigator to be unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
Menstrual Conditions (DRSP, MDQ, PSQ)

Secondary

MeasureTime frame
Secondary outcomes: Mood state, bacterial flora, physiologically active substances, HD5, metabolites, hemoglobin, BDHQ, etc. Safety outcomes: Adverse events and side effects

Countries

Japan

Contacts

Public ContactAkiko Takakuwa

Tenshi College Department of Nutrition School of Nursing and Nutrition

takakuwa@tenshi.ac.jp011-741-1051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026